Prostate Cancer Screening Does Not Lower Death Toll

A study has found that screenings don't affect the disease's death rate.Diseases of the prostate are a widespread problem in the U.S, which is why many men take dietary supplements to maintain good health. One in six men will be diagnosed with prostate cancer in his lifetime, according to the National Cancer Institute. Now, a study has found that screenings don’t affect the disease’s death rate.

Research published in the British Medical Journal determined that men between the ages of 50 and 69 who get screened for prostate cancer every third year die from the disease just as often as those who do not get screened regularly.

The study’s authors noted that such screening did appear to result in overtreatment of prostate ailments.

They suggested that research needs to be done to see if diagnostic tests can be made more sensitive to the differences between fast- and slow-growing tumors.

Men who have prostate difficulties often take saw palmetto extract to reduce inflammation and maintain prostate function.

This compound can be found in a number of inexpensive herbal supplements, many of which also contain healthy levels of vital vitamins and nutrients.